期刊文献+

钙拮抗剂是否稳定型心绞痛治疗的一线药物 被引量:1

原文传递
导出
摘要 治疗慢性稳定型心绞痛(以下简称稳定型心绞痛)有两个主要目的,第一,是预防心肌梗死和降低死亡风险,第二,是减轻心绞痛症状和减少心肌缺血发作。能改善预后的药物都是治疗稳定型心绞痛的一线药物,包括阿司匹林(不能耐受的患者可用氯吡格雷替代)、他汀类药物、血管紧张素转换酶(ACE)抑制剂和β-受体阻滞剂。抗心绞痛药物主要有β-受体阻滞剂、钙拮抗剂和硝酸酯,其中β-受体阻滞剂是大多数指南所推荐的唯一的一线抗心绞痛药物。
作者 施仲伟
出处 《中华心脏与心律电子杂志》 2015年第1期6-9,共4页 Chinese Journal of Heart and Heart Rhythm(Electronic Edition)
  • 相关文献

参考文献21

  • 1Gibborrs RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the Ameriean College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina)[J]. J Am Coll Candiol, 2003, 41(1):159-168.
  • 2Ben-Dor I, Battler A. Treatment of stable angina[ J]. Heart, 2007, 93(7) :868-874.
  • 3Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease [ J ]. Circulation, 1995, 92 (5) : 1326-1331.
  • 4Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies[J]. JAMA, 1995, 274(8) :620-625.
  • 5Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of longacting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment ( ACTION trial) : randomised controlled trial[ J ]. Lancet, 2004, 364 (9437) :849- 857.
  • 6Lubsen J, Wagener G, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial[J]. J Hypertens, 2005, 23(3):641-648.
  • 7Nissen SE, Tuzeu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial[ J]. JAMA, 2004, 292(18) :2217-2226.
  • 8Heidenreich PA, McDonald KM, Hastie T, et al. Metaanalysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina [ J ]. JAMA, 1999, 281 (20) : 1927- 1936.
  • 9The PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease [ J ]. N Engl J Med, 2004, 351 (20) :2058-2068.
  • 10The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin- converting- enzyme inhibitor, ramipril, on cardiovascular events in high- risk patients [ J ]. N Engl J Med, 2000, 342(3) :145-153.

二级参考文献48

  • 1Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 2Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 3Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 4Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 5O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 6Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 7Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 8Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 9Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.
  • 10Kleber AG. ST-segment elevation in the electrocardiogram: a sign of myecaniial iechemia. Cardiovasc Res, 2000,45(1) :111-118.

共引文献6605

同被引文献12

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部